Scientific news

Antibiotics, tumor treatment among medical marijuana studies

Researchers hope that cannabis medicines will be more widely studied as remedies for some of mankind’s most problematic illnesses.

Cannabidiol to treat Dravet syndrome

A recent study published in the New England Journal of Medicine investigates the use of cannabidiol for treating drug resistant seizures in patients with Dravet syndrome.

New research shows cannabidiol (CBD) reduces incision pain

New studies seem to suggest that CBD could be used directly in the control of pain associated with incisions

The Benefits of Cannabinol (CBN): A Lesser Known Cannabinoid

We've all heard of THC and CBD and the many benefits of consuming each, but have you ever heard of CBN (cannabinol)?

Cannabosides show positive results as potential colitis treatment in preclinical studies

Positive preclinical results are stepping stone for Vitality Biopharma to move to first-in-human clinical trials with a new class of cannabinoid prodrugs.

Marijuana stigma hurts doctor–patient relationship, study says

The fear of being labeled a "stoner" can make some patients leave painful symptoms untreated. Others may avoid the doctor entirely.

Could cannabidiol be used to treat ASIA syndrome?

With autoimmune disorders on the rise and standard treatments rendered ineffective, it might be time to look for an alternative solution, such as CBD

US government launches study on medical marijuana and opioid addiction

The National Institutes of Health awarded a $3.8 million grant to Albert Einstein College of Medicine and Montefiore Health System last week.

Crystal structures of agonist-bound human cannabinoid receptor CB1

The cannabinoid receptor 1 (CB1) is the principal target of the psychoactive constituent of marijuana, the partial agonist Δ9-tetrahydrocannabinol (Δ9-THC).

Zynerba Pharma's failed cannabidiol gel trial has upside for rival GW Pharma

GW Pharma’s Epidiolex could be the U.S.’s first cannabis-derived drug.